ZA986475B - Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. - Google Patents

Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Info

Publication number: ZA986475B
Authority: ZA; South Africa
Prior art keywords: carbazoly; propanole; loxy; methoxyphenoxy; ethylamino
Prior art date: 1997-07-22

Application number

ZA9806475A

Other languages

English (en)

Inventor

Erhard Reinholz

Peter Beyer

Original Assignee

Roche Diagnostics Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-22

Filing date

1998-07-21

Publication date

2000-01-21

1998-07-21 Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh

2000-01-21 Publication of ZA986475B publication Critical patent/ZA986475B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

ZA9806475A 1997-07-22 1998-07-21 Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. ZA986475B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97112491A EP0893440A1 (en)	1997-07-22	1997-07-22	Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number	Publication Date
ZA986475B true ZA986475B (en)	2000-01-21

Family

ID=8227094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9806475A ZA986475B (en)	1997-07-22	1998-07-21	Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Country Status (31)

Country	Link
EP (2)	EP0893440A1 (xx)
JP (1)	JP2001510824A (xx)
KR (1)	KR100336229B1 (xx)
CN (1)	CN1125047C (xx)
AR (1)	AR015133A1 (xx)
AT (1)	ATE236123T1 (xx)
AU (1)	AU740453B2 (xx)
BR (1)	BR9810776A (xx)
CA (1)	CA2296637C (xx)
CZ (1)	CZ296947B6 (xx)
DE (1)	DE69812964T2 (xx)
DK (1)	DK1000027T3 (xx)
ES (1)	ES2195366T3 (xx)
HR (1)	HRP980406A2 (xx)
HU (1)	HUP0003198A3 (xx)
IL (1)	IL133677A (xx)
MA (1)	MA26523A1 (xx)
MY (1)	MY117734A (xx)
NO (1)	NO313588B1 (xx)
NZ (1)	NZ502136A (xx)
PE (1)	PE96999A1 (xx)
PL (1)	PL191602B1 (xx)
PT (1)	PT1000027E (xx)
RU (1)	RU2202542C2 (xx)
SI (1)	SI1000027T1 (xx)
TR (1)	TR200000148T2 (xx)
TW (1)	TW505631B (xx)
UY (1)	UY25108A1 (xx)
WO (1)	WO1999005105A1 (xx)
YU (1)	YU2200A (xx)
ZA (1)	ZA986475B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001263813A1 (en) *	2000-04-03	2001-10-15	F.Hoffmann-La Roche Ag	Concentrated solutions of carvedilol
AU2001271639A1 (en)	2000-06-28	2002-01-08	Teva Pharmaceutical Industries Ltd.	Carvedilol
EP1655285A1 (en) *	2000-06-28	2006-05-10	Teva Pharmaceutical Industries Ltd.	Method for preparation of a crystalline form of carvedilol (form II)
JP2004534840A (ja) *	2001-07-13	2004-11-18	スミスクライン・ビーチャム・コーポレイション	カルベジロール多型体
ES2298401T3 (es)	2001-09-21	2008-05-16	Egalet A/S	Dispersiones solidas de liberacion controlada de carvedilol.
WO2003029214A1 (en) *	2001-09-28	2003-04-10	F. Hoffmann-La Roche Ag	Pseudopolymorphic forms of carvedilol
CA2472377A1 (en)	2002-01-15	2003-07-24	Teva Pharmaceutical Industries Ltd.	Crystalline solids of carvedilol and processes for their preparation
AU2003231283A1 (en) *	2002-04-30	2003-11-17	Sb Pharmco Puerto Rico Inc.	Carvedilol monocitrate monohydrate
US20050261355A1 (en)	2002-06-27	2005-11-24	Sb Pharmco Puerto Rico Inc.,	Carvedilol hydobromide
CN103254114A (zh)	2002-06-27	2013-08-21	史密斯克莱.比奇曼（科克）有限公司	卡维地洛磷酸盐和/或其溶剂合物相应的组合物和/或治疗方法
US20040151772A1 (en)	2002-11-08	2004-08-05	Egalet A/S	Controlled release carvedilol compositions
EP1610767B1 (en)	2003-03-26	2011-01-19	Egalet A/S	Morphine controlled release system
WO2004094378A1 (en) *	2003-04-21	2004-11-04	Matrix Laboratories Ltd	Process for the preparation of carvedilol form-ii
SI21616A (sl) *	2003-09-02	2005-04-30	Krka, Tovarna Zdravil, D.D., Novo Mesto	Nove kristalne oblike karvedilola
US7750036B2 (en)	2003-11-25	2010-07-06	Sb Pharmco Puerto Rico Inc.	Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
ATE445601T1 (de) *	2004-12-09	2009-10-15	Zach System Spa	Verfahren zur herstellung von carvedilol und seinen enantiomeren
KR20070088507A (ko) *	2005-06-09	2007-08-29	테바 파마슈티컬 인더스트리즈 리미티드	카베딜올의 결정질 형태 및 이것의 제조 방법
WO2008002683A2 (en)	2006-06-28	2008-01-03	Teva Pharmaceutical Industries Ltd.	Polymorphous forms of carvedilol phosphate
RU2366653C2 (ru) *	2006-07-03	2009-09-10	Ооо "Нанокриохимия"	Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) *	2007-04-04	2008-10-09	Apotex Inc.	Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
WO2008148798A2 (en)	2007-06-04	2008-12-11	Egalet A/S	Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (en)	2009-02-06	2016-12-13	Egalet Ltd.	Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en)	2009-06-24	2013-07-26	Egalet Ltd	Controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2815926A1 (de) *	1978-04-13	1979-10-18	Boehringer Mannheim Gmbh	Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) *	1978-02-09	1979-08-16	Merck Patent Gmbh	1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) *	1983-05-26	1984-11-29	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

1997
- 1997-07-22 EP EP97112491A patent/EP0893440A1/en not_active Withdrawn
1998
- 1998-07-15 MY MYPI98003245A patent/MY117734A/en unknown
- 1998-07-15 PE PE1998000626A patent/PE96999A1/es not_active Application Discontinuation
- 1998-07-18 RU RU2000103033/04A patent/RU2202542C2/ru not_active IP Right Cessation
- 1998-07-18 AU AU86319/98A patent/AU740453B2/en not_active Ceased
- 1998-07-18 CZ CZ20000221A patent/CZ296947B6/cs not_active IP Right Cessation
- 1998-07-18 CN CN98807436A patent/CN1125047C/zh not_active Expired - Fee Related
- 1998-07-18 DK DK98937576T patent/DK1000027T3/da active
- 1998-07-18 DE DE69812964T patent/DE69812964T2/de not_active Expired - Fee Related
- 1998-07-18 HU HU0003198A patent/HUP0003198A3/hu unknown
- 1998-07-18 TR TR2000/00148T patent/TR200000148T2/xx unknown
- 1998-07-18 NZ NZ502136A patent/NZ502136A/en unknown
- 1998-07-18 TW TW087111738A patent/TW505631B/zh not_active IP Right Cessation
- 1998-07-18 SI SI9830442T patent/SI1000027T1/xx unknown
- 1998-07-18 AT AT98937576T patent/ATE236123T1/de not_active IP Right Cessation
- 1998-07-18 YU YU2200A patent/YU2200A/sh unknown
- 1998-07-18 CA CA002296637A patent/CA2296637C/en not_active Expired - Fee Related
- 1998-07-18 JP JP2000504104A patent/JP2001510824A/ja active Pending
- 1998-07-18 BR BR9810776-3A patent/BR9810776A/pt not_active Application Discontinuation
- 1998-07-18 KR KR1020007000667A patent/KR100336229B1/ko not_active Expired - Fee Related
- 1998-07-18 PT PT98937576T patent/PT1000027E/pt unknown
- 1998-07-18 ES ES98937576T patent/ES2195366T3/es not_active Expired - Lifetime
- 1998-07-18 EP EP98937576A patent/EP1000027B1/en not_active Expired - Lifetime
- 1998-07-18 IL IL13367798A patent/IL133677A/en not_active IP Right Cessation
- 1998-07-18 PL PL338432A patent/PL191602B1/pl unknown
- 1998-07-18 WO PCT/EP1998/004475 patent/WO1999005105A1/en not_active Ceased
- 1998-07-20 MA MA25178A patent/MA26523A1/fr unknown
- 1998-07-21 ZA ZA9806475A patent/ZA986475B/xx unknown
- 1998-07-21 AR ARP980103547A patent/AR015133A1/es unknown
- 1998-07-22 HR HR97112491.2A patent/HRP980406A2/hr not_active Application Discontinuation
- 1998-07-22 UY UY25108A patent/UY25108A1/es not_active IP Right Cessation
2000
- 2000-01-21 NO NO20000301A patent/NO313588B1/no unknown

Also Published As

Publication number	Publication date
KR100336229B1 (ko)	2002-05-09
HRP980406A2 (en)	1999-04-30
SI1000027T1 (en)	2003-10-31
CA2296637C (en)	2005-11-15
DE69812964T2 (de)	2004-03-04
CZ2000221A3 (cs)	2000-05-17
AU740453B2 (en)	2001-11-01
NO20000301L (no)	2000-01-21
KR20010022097A (ko)	2001-03-15
MY117734A (en)	2004-07-31
AR015133A1 (es)	2001-04-18
CN1125047C (zh)	2003-10-22
CZ296947B6 (cs)	2006-08-16
ATE236123T1 (de)	2003-04-15
MA26523A1 (fr)	2004-12-20
EP1000027B1 (en)	2003-04-02
NO313588B1 (no)	2002-10-28
WO1999005105A1 (en)	1999-02-04
RU2202542C2 (ru)	2003-04-20
CN1264366A (zh)	2000-08-23
HUP0003198A3 (en)	2002-10-28
PL338432A1 (en)	2000-11-06
YU2200A (sh)	2002-03-18
HK1029339A1 (en)	2001-03-30
PL191602B1 (pl)	2006-06-30
TW505631B (en)	2002-10-11
IL133677A (en)	2004-06-01
UY25108A1 (es)	2000-12-29
HUP0003198A2 (en)	2001-03-28
DE69812964D1 (de)	2003-05-08
ES2195366T3 (es)	2003-12-01
PE96999A1 (es)	1999-10-12
AU8631998A (en)	1999-02-16
IL133677A0 (en)	2001-04-30
TR200000148T2 (tr)	2000-07-21
BR9810776A (pt)	2000-09-19
DK1000027T3 (da)	2003-07-21
JP2001510824A (ja)	2001-08-07
EP1000027A1 (en)	2000-05-17
PT1000027E (pt)	2003-07-31
NZ502136A (en)	2002-05-31
NO20000301D0 (no)	2000-01-21
CA2296637A1 (en)	1999-02-04
EP0893440A1 (en)	1999-01-27

Similar Documents

Publication	Publication Date	Title
ZA986475B (en)	2000-01-21	Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.
EP1001813B8 (en)	2014-02-12	Pharmaceutical formulations containing voriconazole
AU1157599A (en)	1999-05-31	Pyrimidinone compounds and pharmaceutical compositions containing them
ZA988585B (en)	2000-03-13	Pharmaceutical compositions containing plasma protein.
HUP0000851A3 (en)	2002-04-29	Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0001539A3 (en)	2003-01-28	2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
HUP0001541A3 (en)	2001-11-28	Phthalazinone derivatives and pharmaceutical compositions containing them
HU0500549D0 (en)	2005-08-29	Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL159086A0 (en)	2004-05-12	3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
IL138280A0 (en)	2001-10-31	20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0102372A3 (en)	2003-01-28	Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same
ZA9710015B (en)	1998-05-25	Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications.
WO1999054286A3 (en)	2000-05-04	Btk inhibitors and methods for their identification and use
AU6120498A (en)	1998-09-22	4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them
HUP9601328A3 (en)	1999-04-28	4-(aryl-amino-methylene)-2,4-dihydro-pyrazol-3-one derivatives and pharmaceutical compositions containing them
HUP9902138A3 (en)	2001-10-29	N-[4-(heteroarylmethyl)phenyl]-heteroarylamine derivatives, their preparation and pharmaceutical compositions containing them
ZA984216B (en)	1999-11-19	Clear emulsion cosmetic compositions.
IL138725A0 (en)	2001-10-31	Sulfonamide derivatives and pharmaceutical compositions containing the same
HUP0002853A3 (en)	2001-12-28	6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
ZA961138B (en)	1997-08-13	Solid active ingredient compositions containing hydroxypropylcellulose.
ZA991590B (en)	1999-08-27	Indole derivatives and pharmaceutical compositions comprising the same.
ZA989680B (en)	1999-07-23	Pharmaceutical composition.
ZA991181B (en)	1999-08-16	Thickened emulsion compositions for use as propellants and explosives.
NO20012727D0 (no)	2001-06-01	3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
AU5892399A (en)	2000-03-21	1, 2, 4-triazole-3-thione compounds